arrow
S

Soumya Surath Panda

Institute of Medical Sciences and SUM Hospital
H指数:7
被引数:410

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India

曲妥珠单抗emtansine生物类似物(UJVIRA®)在早期和转移性HER2阳性乳腺癌中的真实世界疗效与安全性:一项来自印度的多中心合并回顾性分析

2026-10-280
PRE
Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India

PARP抑制剂在BRCA突变或HRD阳性晚期卵巢癌一线维持治疗中的真实世界数据:一项来自印度的多中心回顾性研究

2026-02-070
OAAI
Utility of Flow Cytometry in Diagnosis of Lymphomas from Tissue Samples

流式细胞术在组织样本淋巴瘤诊断中的应用价值

2025-12-010
PRE
Myeloid sarcomas of the genitourinary tract: A multi-institutional study of sixteen tumors with review of literature

泌尿生殖道髓系肉瘤:一项多机构十六例肿瘤研究及文献综述

2025-07-030
PRE
Real-world data of PARP inhibitors in first-line maintenance for BRCA mutated or HRD positive advanced ovarian cancer: A multicenter retrospective study from India

PARP抑制剂在BRCA突变或HRD阳性晚期卵巢癌一线维持治疗中的真实世界数据:一项来自印度的多中心回顾性研究

2024-12-010
PRE
Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India
2024-05-012
PRE